Local News: Waverly, MN 

 | 

Sign Up

 | 

Sign In

Advertisment

Diovan, Valsartan Wire

Comprehensive News Feed for Diovan, Valsartan (generic).

Results 1 - 15 of 15 in Diovan, Valsartan (generic)

  1. Updated European guidelines highlight benefits of Rasilez, the only...Read the original story

    Wednesday Oct 28 | Drugs.com

    Rasilez, a first-in-class direct renin inhibitor , works at the point of activation of the renin angiotensin aldosterone system , directly inhibiting the activity of renin, an enzyme that triggers a process that may lead to high blood pressure and organ damage2,3. The updated European Guidelines on Hypertension Management, appraised by an ESH task ...

    Comment?

    Related Topix: Medicine, Hypertension, Health, Diabetes

  2. Novartis Receives Approval in the European Union for Exforge HCTA

    Friday Oct 23 | Health News Digest

    Basel, - The European Commission has granted Novartis marketing authorization for Exforge HCT , a new 3-in-1 treatment for people with high blood pressure.

    Comment?

    Related Topix: Medicine, Hypertension, Health, Marketing, Medication

  3. Research and Markets: Key Attractions of the Malaysian Pharmaceutical ...Read the original story

    Monday Oct 19 | BusinessWire

    Research and Markets: Key Attractions of the Malaysian Pharmaceutical Market Are the Government's Encouragement of the Biotechnology Sector Says This Q4 2009 Report The Malaysia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and ...

    Comment?

    Related Topix: Biotech, Science / Technology

  4. Waiting for New Novartis HBP DrugRead the original story

    Sep 28, 2009 | Seeking Alpha

    Novartis is expected to launch its high blood pressure drug Valturna shortly after the recent US Food and Drug Administration approval.

    Comment?

    Related Topix: Biotech, Novartis, Medicine, Hypertension, Health, Healthcare Law, Law, Food and Drug Administration, Medication

  5. Novartis Drug Gets Fda OkRead the original story

    Sep 18, 2009 | Zacks Analyst Blog

    Snapshot Report ) Valturna for high blood pressure. The drug is a single-pill combination of Diovan , an angiotensin receptor blocker, and Tekturna , the only approved direct renin inhibitor.

    Comment?

    Related Topix: Medicine, Hypertension, Health, Medication, Biotech, Merck , Healthcare Industry

  6. Novartis gets FDA Approval for Blood Pressure Drug

    Sep 18, 2009 | Pharmaceutical Processing

    The drug is a single-pill combination of valsartan and aliskiren. Valsartan is the active ingredient in Novartis' high blood pressure drug Diovan while aliskiren is the active ingredient in the company's blood pressure drug Tekturna.

    Comment?

    Related Topix: Medicine, Hypertension, Health, Medication

  7. Novartis Gains Approval for Valturna Combo

    Sep 18, 2009 | Contract Pharma Breaking News

    The FDA has approved Novartis ' Valturna tablets, a medicine targeting two key points within the renin system, also known as the renin angiotensin aldosterone system , a regulator of blood pressure.

    Comment?

    Related Topix: Medicine, Medication, Healthcare Law, Law, Hypertension, Health

  8. Novartis Corporation Receives FDA Approval for Valturna(R), a...Read the original story

    Sep 18, 2009 | BioSpace

    The US Food and Drug Administration has approved Valturna tablets, the first and only medicine to target two key points within the renin system, also known as the renin angiotensin aldosterone system , an important regulator of blood pressure.

    Comment?

    Related Topix: Medicine, Medication, Healthcare Law, Food and Drug Administration, Law, Biotech, Healthcare Industry, Hypertension, Health

  9. Novartis Receives FDA Approval For Valturna(R), A Single-Pill...Read the original story

    Sep 18, 2009 | Medical News Today

    Main Category: Hypertension Also Included In: Regulatory Affairs / Drug Approvals ; Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 18 Sep 2009 - 2:00 PDT The US Food and Drug Administration has approved Valturna ) tablets, the first and only medicine to target two key points within the renin system, also known as ...

    Comment?

    Related Topix: Medicine, Hypertension, Health, Healthcare Law, Food and Drug Administration, Law, Medication

  10. Novartis Receives FDA Approval For Valturna , A Single-Pill...Read the original story

    Sep 18, 2009 | Pharmaceutical Online

    September 18, 2009 Valturna combines in a single pill valsartan, an angiotensin receptor blocker, with aliskiren, the only approved direct renin inhibitor Valturna is the first therapy to target two points within the renin angiotensin aldosterone system , which plays a key role in regulating blood pressure Valturna offers significantly greater ...

    Comment?

    Related Topix: Medicine, Medication, Healthcare Law, Food and Drug Administration, Law, Hypertension, Health

  11. Good news for Asian Canadians with uncontrolled hypertensionRead the original story

    Sep 14, 2009 | Canada NewsWire

    A total of 3,031 Japanese patients with uncontrolled high blood pressure either with no treatment or on a previous non-ARB-based regimen and with one or more pre-defined cardiovascular risk factors took part in the study.

    Comment?

    Related Topix: Medicine, Hypertension, Health, Medication

  12. Research and Markets: Forecast Insight: Antihypertensives New Fixed...Read the original story

    Sep 3, 2009 | BusinessWire

    Following the patent expiries of ARBs Datamonitor expects antihypertensives sales in the seven major markets to record sales of $29.5 billion in 2018, a drop of over $6 billion compared to 2008.

    Comment?

    Related Topix: Medicine, Hypertension, Health, 9, Best of 2007

  13. In Heart Failure Patients Treated With ACE Inhibitor And/or Beta...

    Sep 2, 2009 | Medical News Today

    Main Category: Cardiovascular / Cardiology Also Included In: Heart Disease Article Date: 02 Sep 2009 - 2:00 PDT Data confirm that in heart failure patients being treated with ACE inhibitor and/or beta blocker, higher plasma renin activity still predicts greater risk of mortality1.

    Comment?

    Related Topix: Medicine, Medication, Italy, World News, Toscana, Italy, Florence, Italy, Health

  14. New Data Confirm That Diovan(R) And Valsartan-Based Combinations...Read the original story

    Jun 15, 2009 | Medical News Today

    Data presented at the 19th Scientific Meeting of the European Society of Hypertension confirm that Diovan and valsartan-based combinations deliver sustained, 24-hr blood pressure -lowering efficacy2-6. Studies have suggested that the relative risks of acute myocardial infarction, stroke and sudden cardiac death are 40%, 49% and 29% higher, ...

    Comment?

    Related Topix: Medicine, Medication, Hypertension, Health, Bonn, Germany, World News, Germany, Food and Drug Administration

  15. New Data Confirm That Diovan(R) And Valsartan-Based Combinations...

    Jun 15, 2009 | MediLexicon

    Data presented at the 19th Scientific Meeting of the European Society of Hypertension confirm that Diovan and valsartan-based combinations deliver sustained, 24-hr blood pressure -lowering efficacy2-6. Studies have suggested that the relative risks of acute myocardial infarction, stroke and sudden cardiac death are 40%, 49% and 29% higher, ...

    Comment?

    Related Topix: Medicine, Medication, Hypertension, Health, Bonn, Germany, World News, Germany, Food and Drug Administration